Are Amicus Therapeutics (FOLD) and Autoliv (ALV) Overlooked Opportunities

Related Articles

What Does Recent Insider Selling at Autoliv (ALV) Signal

5 months ago

Amicus Therapeutics: A Rare Disease Gem Acquired

5 months ago

Is Fold Holdings (FLD) COO's Stock Sale a Red Flag for Investors

3 months ago

Is the AI Hype Cycle Still Driving Small-Cap Opportunities

5 months ago

Category

You may also like

Stock News•1 week ago

5 Broker-Loved Stocks to Watch as September Rate Hike Seems Unlikely

Broker-favored stocks including Avnet, RXO, Forward Air, Air Canada, and AMN Healthcare are in focus after weak July jobs data dims September rate-hike odds, potentially supporting valuations if rates...

AMN

Share

Stock News•1 months ago

ALTO Trades at a Discount Despite 344% Rally in a Year: What's Next?

ALTO shares surged 344% in the past year, driven by improving profitability and favorable market trends, yet the stock still trades at a discount.

ALTO

Share

Stock News•1 months ago

Are Medical Stocks Lagging Acumen Pharmaceuticals (ABOS) This Year?

Acumen Pharmaceuticals (ABOS) has outperformed the medical sector year-to-date, while Amarin (AMRN) has lagged.

ABOS

Share

Stock News•1 months ago

Autoliv, Inc. (ALV) Reports Next Week: Wall Street Expects Earnings Growth

Autoliv (ALV) reports earnings next week. Wall Street expects growth, but the company lacks the key ingredients for a likely earnings beat per current analysis.

ALV

Share